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Abstract 26 
Nowadays, at least four clinically important B. burgdorferi sensu lato (s.l.) genospecies 27 
(B. afzelii, B. garinii, B. burgdorferi sensu stricto (s.s.) and B. lusitaniae) circulate in 28 
Portugal. Each genospecies have different tropism that result in a diverse array of clinical 29 
manifestations. The standard diagnostic procedure used is normally simple, nevertheless, 30 
during the “window-period” phase, in which specific antibodies cannot yet be detected, 31 
diagnosis becomes difficult, and calls for reliable, sensitive and specific laboratory 32 
methods, such as molecular tests. The aim of this study was to develop and evaluate a 33 
multiplex TaqMan real-time PCR assay to infer the presence of B. burgdorferi s.l. 34 
genospecies in clinical and vector-derived samples. The assay consists of two steps: (i) a 35 
first duplex real-time PCR targeting both flaB of B. burgdorferi s.l., and an internal 36 
control (18S rDNA for tick samples or the mammal β-actin gene for clinical samples); 37 
and (ii) a second tetraplex real-time PCR targeting the flaB gene of B. afzelii, B. garinii, 38 
B. burgdorferi s.s. and B. lusitaniae.  39 
The first step revealed a high specificity and sensitivity, allowing the detection of as low 40 
as 20 genome equivalents (GE) of B. burgdorferi s.l. from isolated cultures, clinical 41 
samples and ticks. The second step revealed high specificity, but a slightly lower 42 
sensitivity (2×102 GE) for detection of B. afzelii, B. garinii, B. burgdorferi s.s. and B. 43 
lusitaniae in purified DNA extracts, and more particularly when testing cerebrospinal 44 
fluid (CSF) samples. Nonetheless, both real-time PCR protocols were developed to be 45 
applied at the beginning of the infection, to improve early diagnosis of Lyme borreliosis 46 
(LB), where detection of Borrelia should not rely on the use of CSF samples. The assay 47 
here described is of special interest for the analysis of both environmental and clinical 48 
samples, being advantageous in the former phase screening of Lyme borreliosis, when 49 
the efficiency of serologically based diagnoses may be seriously compromised.   50 
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Introduction 54 
Lyme borreliosis (LB) is known as the most common vector-borne disease in both Europe 55 
and North America (ECDC, 2016). The number of cases in the last two decades points to   56 
360 000 cases in Europe (with a marked increase)  (ECDC, 2014), and approximately 57 
300 000 cases in the USA, between 1995 and 2015 (Lindgren & Jaenson, 2006; Hinckley 58 
et al., 2014). Nearly all human cases in Europe are caused by three members of the B. 59 
burgdorferi sensu lato (s.l.) complex, namely B. garinii, B. afzelii, and B. burgdorferi 60 
sensu stricto (s.s.) (Rizzoli et al., 2011), all of which are transmitted through the bite of 61 
Ixodes ricinus ticks. In the USA, B. burgdorferi s.s. was the only species associated to 62 
LB. However, more recently Candidatus B. mayonii was also identified as the causative 63 
agent of LB  (Stanek et al., 2012, Pritt et al., 2016).  64 
The clinical manifestations of LB are wide-ranging, and linked with differential bacterial 65 
tropisms for distinct tissues or systems (van Dam et al., 1993; Balmelli & Piffaretti, 1995). 66 
Early localized infections typically result in a rash known as erythema migrans (EM), 67 
from which spirochetes can disseminate to the central and peripheral nervous systems, 68 
joints, and other organs. Infections with B. burgdorferi s.s. are usually associated with 69 
arthritis, while those caused by B. garinii and B. afzelii are usually accompanied by 70 
neurological and skin complications (e.g. Bell’s palsy, encephalopathy and acrodermatitis 71 
chronica atrophicans – ACA), respectively (van Dam et al., 1993). Nevertheless, LB may 72 
also remain latent, without an unequivocal clinical presentation, or translate into a clinical 73 
presentation including unspecific symptoms such as headache, myalgia, arthralgia or 74 
fever (Smith et al., 2002; Steere et al., 2003). 75 
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Currently, in case the affected individual reports recent tick bites, or shows symptoms 76 
typical of EM the standard diagnosis is clinical. However, when a laboratory confirmation 77 
of a clinical diagnosis is required, several direct as well as indirect methods may be used. 78 
Direct detection of B. burgdorferi s.l. spirochetes may be carried out by examination of 79 
specimens under dark-field microscope, detection of bacterial DNA using conventional 80 
polymerase chain reaction (PCR), and culture in individual cases where the clinical 81 
picture suggests LB despite a negative antibody assay (e.g. in atypical EM or in suspected 82 
acute neuroborreliosis without detection of intrathecal antibodies) (Gaumond et al., 2006, 83 
Marques, 2015). However, this is a very time-consuming method characterized by a low 84 
sensitivity, especially in body fluids (Wilske, 2007). Indirect diagnostic methods, 85 
involving the detection of IgM/IgG anti-B. burgdorferi s.l. antibodies, may be performed 86 
by ELISA, EIA and immunoblot tests (Steere et al., 2008; Hinterseher et al., 2012; Liu et 87 
al., 2013). Despite their generalized use, the available serological tests are frequently 88 
unsuitable or insufficient for a conclusive diagnosis due to high levels of cross-reactivity 89 
between anti-B. burgdorferi s.l. antibodies and non-Borrelia antigens, which compromise 90 
the distinction between primary and recurrent infections, and the identification of bona-91 
fide infections during the immunological window period (Marques, 2015).  92 
PCR-based assays have been proven useful to screen for B. burgdorferi s.l. cases in an 93 
early phase, before the development of an immune response and production of IgM/IgG 94 
antibodies. These assays allow the detection of the spirochete’s genome in biological 95 
samples without requiring their cultivation by targeting chromosomal genes such as recA, 96 
flaB, plasmid genes ospA, ospC, 16S rDNA, or the rrs-rrlA intergenic spacer (16S-23S 97 
IGS) (Schmidt, 1997; Lebech, 2002).  98 
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The aim of this study was to develop an easy-to-use TaqMan real-time PCR assay for the 99 
detection of B. burgdorferi s.l. spirochetes, also allowing the differentiation of clinically-100 
relevant species of the complex.   101 
 102 
Material and methods 103 
TaqMan probes and flanking primers 104 
 A multiple sequence alignment of flaB [located in the bacterial linear chromosome, 105 
which encodes a 41-kDa flagellin protein (Wang,1999)] reference sequences retrieved 106 
from GenBank was created using Mafft 7 (Katoh  Standley, 2013). The flagellin-coding 107 
sequences used included those of B. burgdorferi s.s. B31 (accession number 108 
CP009656.1), B. garinii SZ (accession number CP007564.1), B. afzelii HLJ01 (accession 109 
number CP003882.1), B. bavariensis PBi (accession number NC_006156.1), B. 110 
valaisiana VS116 (accession number AB236666.1), B. bissettiae CA128 (accession 111 
number DQ393343), B. lusitaniae PoTiB1 (accession number DQ111035.1), B. 112 
californiensis CA446 (accession number DQ393347.1), B. spielmanii A14S (accession 113 
number ABKB020000003.1) and B. sinica CMN3 (accession number AB022138.1). 114 
These multiple sequence alignments supported the design of primers and TaqMan probes 115 
(labelled with fluorophores with different emission spectra), targeting the B. burgdorferi 116 
s.l. complex, and each of the four main species circulating in Europe (B. burgdorferi s.s., 117 
B. afzelii, B. garinii and B. lusitaniae). Borrelia-targeted primers and probes (Table 1) 118 
were designed using a combination of tools, including Primer Express 3.0 (Applied 119 
Biosystems) and BLAST (Altschul et al., 1997). Additional sets of primers and probes 120 
were also used as controls to detect ixodid 18S rDNA (Table 1), and the mammal β-actin- 121 
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coding-sequence (ACTB) (Costa et al., 2013), for assessment of PCR inhibition when 122 
DNA extracts from clinical samples or ixodid ticks were used as template.  123 
 124 
Two-step multiplex real-time PCR  125 
The algorithm used for the amplification-based screening of B. burgdorferi s.l. involves 126 
two steps (Figure 1). The first comprised a duplex real-time PCR, targeting both flaB  127 
gene (for the detection and quantification of B. burgdorferi s.l.), and an internal control  128 
(18S rDNA when using DNA extracts from adult ticks homogenates as template, or the 129 
β-actin gene when using DNA extracts from clinical samples). Samples for which 130 
positive amplification results were obtained (flaB/18S rDNA or flaB/ACTB), were further 131 
analyzed by a tetraplex real-time PCR specifically targeting the flaB gene of B. afzelii, B. 132 
garinii, B. lusitaniae and B. burgdorferi s.s. (Figure 1. Amplification protocols were 133 
optimized using DNA extracted from pure cultures of B. burgdorferi s.l. as template. 134 
Duplex real-time PCR reactions were carried out in a total volume of 20 μl using 135 
SensiFAST™ amplification mix (Bioline), 0.3 μM of each primer (F_Bbsl, R_Bbsl; 136 
F_18S rDNA, R_18S rDNA or F_β-actin, R_ β-actin), 0.25 μM of each TaqMan probe 137 
(P_Bbsl; P_18S rDNA or P_ β-actin), DNase-free water (Bioline), and 2 μl of extracted 138 
DNA template (corresponding to 20-40 ng of total DNA). The thermal cycling conditions 139 
were: 1 cycle at 95 °C for 1 min, followed by 40 cycles at 95 °C for 10 s and 60 °C for 140 
45 s. Tetraplex real-time PCR reactions used SensiFAST™ amplification mix, 0.3 μM of 141 
F_Bspp, R_Bspp primers, and 0.25 μM of P_Bafz, P_Bgar, P_Bbss and 0.15 μM of 142 
P_Blus TaqMan probes in a total volume of 20 μl. The thermal cycling conditions were: 143 
1 cycle at 95°C for 5 min, followed by 45 cycles at 95 °C for 10 s and 60°C for 30 s. All 144 
samples with positive amplification results were retested for confirmation. Non-template 145 
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negative controls were included in each run to rule out the possibility of false-positive 146 
results due to cross-contamination. Thermal cycling, fluorescent data collection, and data 147 
analysis were performed in a 7500 Fast real-time PCR System (Applied Biosystems), 148 
according to the manufacturer’s instructions. 149 
 150 
B. burgdorferi s.l. reference strains 151 
B. burgdorferi s.s. (B31), B. afzelii (PGau), B. garinii (PBi), B. lusitaniae (PoHL1), B. 152 
bavariensis (PBi) and B. valaisiana (VS116) (maintained as part of the collection of 153 
reference strains at the Leptospirosis and Lyme Borreliosis laboratory at IHMT/UNL), 154 
were cultured in BSK-H medium at 34 ºC, and the growth was regularly followed by 155 
observation under a dark-field microscope and evaluation of optical density (OD) by 156 
spectrophotometric analysis (600 nm). When the cultures reached the exponential growth 157 
phase (OD≈0.5), bacteria were harvested by centrifugation at 14,000×g, and their 158 
genomic DNA extracted with the Gentra Puregene commercial kit (QIAGEN®), 159 
according to the manufacturer’s instructions. DNA concentration and purity were 160 
estimated using a NanoDrop 1000 spectrophotometer (NanoDropTM). The DNA 161 
concentration was adjusted to 106 GE for the six B. burgdorferi s.l. genospecies and 162 
dilutions from 106 to 10 GE were prepared.  163 
 164 
Analytical specificity and sensitivity 165 
To investigate whether the designed probes and respective flanking primers were able to 166 
specifically detect their targets, PCR amplifications were carried out using as template 167 
DNA from B. burgdorferi s.l., and also DNA templates extracted from three other 168 
spirochetes (Borrelia miyamotoi, Leptospira interrogans and Treponema pallidum), and 169 
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from tick-borne piroplasms (Theileria sp. and Babesia sp.; Step A1 in Supplementary 170 
Figure 1).  171 
To estimate the detection threshold (analytical sensitivity) of the duplex real-time PCR 172 
(involving partial amplification of flaB sequences plus an internal control) the template 173 
used corresponded to genomic DNA extracted from pure cultures of B. burgdorferi s.s., 174 
B. garinii, B. afzelii, B. lusitaniae, B. bavariensis and B. valaisiana. Likewise, the 175 
evaluation of the sensitivity of the tetraplex real-time PCR step (exclusively involving 176 
partial amplification of flaB) was carried out using extracts of B. afzelii, B. garinii, B. 177 
lusitaniae and B. burgdorferi s.s. genomic DNA. For each PCR step (duplex and 178 
tetraplex) a standard curve was constructed using 10-fold serial dilutions of the prepared 179 
DNA extracts, tested either individually or as mixtures of each of the templates used (in 180 
equivalent amounts; Step B in Supplementary Figure 1). These dilutions ranged from 106 181 
to 10 GE (10 GE = 50 fg of DNA), as defined by the National Reference Centre for 182 
Borrelia (NRZ units) and according to Rijpkema et al., 1997. PCR assays were performed 183 
in triplicate. The end-point corresponded to the last dilution for which the assay could 184 
still detect the respective DNA targets in all three replicates. 185 
To ascertain whether the real-time PCR assays could be applied to the analysis of clinical 186 
samples, aliquots of human sera were spiked with a 10-fold serial dilution of B. 187 
burgdorferi s.l. DNA, using equivalent amounts of DNA from B. burgdorferi s.s., B 188 
afzelii, B. garinii and B. lusitaniae, ranging from 106 to 10 of GE (Step C in 189 
Supplementary Figure 1). Total DNA was re-extracted from this mixture using the Gentra 190 
Puregene commercial kit (QIAGEN®), according to the manufacturer’s instructions. 191 
Experimentally spiked samples were screened by two conventional PCR (Rijpkema et al., 192 
1995; Wodecka et al., 2010), as well as the two real-time PCR assays here described.  193 
 194 
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Evaluation of real-time PCR with field-collected ticks and clinical samples 195 
A panel of human samples (Table 2), was used to assess the performance of the two-step 196 
real-time PCR assay. The panel included samples of sera (n=20) and CSF (n=10) 197 
collected between 2012 and 2015 by the Leptospirosis and Lyme Borreliosis Group 198 
(IHMT/UNL), that having been anonymized prior to testing (Step D in Supplementary 199 
Figure 1). Also samples of questing nymphs and adult specimens of Ixodes ricinus 200 
(n=50), collected across Portugal in former studies (Nunes et al., 2015; Nunes et al., 2016; 201 
Step D in Supplementary Figure 1), were analyzed. The presence of B. burgdorferi s.l. 202 
DNA in all these samples had been formerly evaluated by two nested-PCR assays 203 
targeting the 23S-5S intergenic spacer region (Rijpkema et al., 1995) and flaB (Wodecka 204 
et al., 2010). Nested-PCR amplification products from tick samples had also been 205 
previously sequenced for the identification of B. burgdorferi s.l. genospecies.  The entire 206 
study was carried out in strict accordance with protocols approved by the Institute of 207 
Hygiene and Tropical Medicine Ethics Committee, and the Portuguese Data Protection 208 
Authority.  209 
 210 
Statistical analysis 211 
For measuring the agreement between the results of the routinely performed molecular 212 
identification of clinical and tick samples, and the real-time PCR assay, kappa coefficient 213 
(k) was used. This coefficient, with confidence intervals, was determined with BioEstat 214 
5.0.  215 
 216 
 217 
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Results 218 
Analytical specificity and sensitivity 219 
The real-time PCR assays optimized in the course of this work (duplex + tetraplex) 220 
allowed detecting B. burgdorferi s.l. DNA with high specificity as unspecific 221 
amplification products were not detected when DNA extracts from B. miyamotoi, T. 222 
pallidum, L. interrogans, Theileria sp. or Babesia sp. were used as template in repeated 223 
experiments (Step A1 in Supplementary Figure 1). In addition, no false positive results 224 
were ever detected when the four Borrelia species-specific probes were tested using as 225 
template DNA extracts of B. burgdorferi s.s., B. afzelii, B. garinii and B. lusitaniae. 226 
TaqMan probes designed were shown to be specific for their respective targets. 227 
For the evaluation of the sensitivity of the assay, flaB sequences were tentatively detected 228 
in serial dilutions (from 106 to 10 GE) of extracts of DNA prepared from pure cultures of 229 
B. burgdorferi s.l. (B. burgdorferi s.s., B. afzelii, B. garinii, B. lusitaniae, B. bavariensis, 230 
and B. valaisiana). For the duplex real-time PCR (aiming at B. burgdorferi s.l. detection) 231 
flaB amplification was carried out either using each individual DNA extract per se, or an 232 
equivalent mixture of all of them (serially diluted to 10 GE). The sensitivity of the 233 
tetraplex real-time PCR was evaluated using a similar approach, i.e. with dilutions of 234 
DNA from B. burgdorferi s.s., B. afzelii, B. garinii and B. lusitaniae, tested individually 235 
and as a mixture (Step B in Supplementary Figure 1).  236 
The first duplex reaction could detect the presence of B. burgdorferi s.l. down to 100 fg 237 
of template DNA (equivalent to 20 GE; Figure 3A), regardless of the genospecies tested 238 
(Step B1 in Supplementary Figure 1). The standard curve for DNA mixture showed a 239 
correlation coefficient (R2) of 0.98 and a slope of – 3.2, corresponding to an efficiency of 240 
105,35% (Figure 2B). For the tetraplex reaction, when each probe was tested individually, 241 
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the detection limit was 100 fg = 20 GE for B. afzelii (Ct ≈ 37), B. garinii (Ct ≈ 37) and B. 242 
lusitaniae (Ct ≈ 37) and 1 pg = 2×102 GE for B. burgdorferi s.s. (Ct ≈ 36), (a 243 
representative example for B. lusitaniae is shown in Figure 3A); when tested in tetraplex, 244 
the detection limit was 1 pg = 2×102 GE for B. afzelii (Ct ≈ 32), B. garinii (Ct ≈ 35), B. 245 
lusitaniae (Ct ≈ 35) and B. burgdorferi s.s. (Ct ≈ 35), a representative example for 2×106 246 
GE is shown in Figure 3B; Step B1 in Supplementary Figure 1). The standard curves for 247 
the tetraplex reaction showed correlation coefficients (R2) ranging from 0.929 to 0.997 248 
and slopes of -2.296 to -3.377 (Figure 3C). 249 
 250 
Experimentally spiked serum samples 251 
A series of DNA extracts purified from human sera samples spiked with B. burgdorferi 252 
s.l. DNA was screened using the optimized duplex and tetraplex real-time PCR assays. 253 
The duplex assay could detect down to 20 GE of Borrelia DNA, with a Ct value of 35 254 
(Step C1 in Supplementary Figure 1). The tetraplex assay, could detect 2×102 GE for each 255 
of the four genospecies tested, to which corresponded Ct values of 32 for B. afzelii and 256 
B. burgdorferi s.s., 35 for B. garinii, and 34 for B. lusitaniae (Step C1 Supplementary 257 
Figure 1). 258 
 259 
Field-collected ticks and clinical samples 260 
From the 50 tick samples tested, 24 were previously positive using the two conventional 261 
nested-PCR assays (see Materials and methods) for the presence of B. burgdorferi s.l. 262 
DNA. Furthermore, these tick samples were also tested by the two real-time PCR 263 
protocols, being 24 samples positive by the duplex real-time PCR (100%, test k = 1.000), 264 
and 23 by the tetraplex real-time PCR, (96%, test k = 0.960) (Table 2). The genospecies 265 
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of B. burgdorferi s.l. identified by the tetraplex were in agreement with those previously 266 
defined by DNA sequencing (Table 2).  Regarding the 26 tick samples for which the 267 
nested-PCRs could not detect the presence of Borrelia DNA, the real-time PCR 268 
approaches also confirmed the apparent absence of Borrelia in these samples.  269 
A similar algorithm was used for the analysis of the clinical samples (n=30), including 270 
sera and CSF, being 11 (37%, n=5 sera, n=6 CSF) positive by the nested-PCR protocols, 271 
for Borrelia DNA, and also by the duplex real-time PCR. However, only three of the 272 
samples (10% of the total of clinical samples analyzed) were positive using the tetraplex 273 
assay. The genospecies of B. burgdorferi s.l. identified included B. afzelii; B. garinii and 274 
B. lusitaniae (Table 2). The calculated k values were 0.920 for the duplex assay (taking 275 
into account the results obtained for sera and CSF samples), and 0.692 for the tetraplex 276 
assay, considering only the results obtained for the sera samples (since there were no 277 
positive results when CSF samples were tested).   278 
Discussion 279 
According to the European Center for Disease Prevention and Control (ECDC, 2016), the 280 
diagnosis of infections caused by Borrelia spp should be based on the identification of 281 
clinical symptoms, on the analysis of the patient’s medical history (evaluation of the risk 282 
of exposure to infected ticks), along with laboratory testing for detection of IgM/IgG 283 
specific antibodies (Bil-Lula et al., 2015). However, the serologic tests used for detection 284 
of an immune response against these bacteria give rise to large numbers of false negative 285 
results, most probably due to the kinetics of IgM production, which are absent during the 286 
so-called “window period”. Consequently, the development of molecular approaches for 287 
detection of these bacteria, and especially those based on real-time PCR, would be helpful 288 
for testing early-onsets of disease, before an antibody response develops. These tools 289 
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would also prove valuable for laboratory diagnosis of infections caused by Borrelia spp. 290 
in biological samples collected from patients presenting non-classic symptoms.  291 
Different Borrelia genospecies are associated with diverse hosts (Mannelli et al., 2012), 292 
different clinical presentations (van Dam et al., 1993), severity of disease (Jungnick et al., 293 
2015), and geographic distribution  (Stanek & Strle, 2003). Consequently, it is 294 
increasingly important to detect and identify the diverse Borrelia genospecies involved 295 
in any given infection.  296 
This work describes, for the first time, the development of a tetraplex PCR protocol for 297 
detection/quantification of four of the most prevalent Borrelia genospecies in Europe. 298 
The assay in question corresponds to a combined multiplex TaqMan real-time PCR 299 
strategy to infer the presence of B. burgdorferi s.l. genospecies in both clinical and vector 300 
samples. In a first step, the presence of Borrelia spp is revealed by targeting flaB gene, 301 
while an internal control is used, to monitor PCR inhibitions, targeting either tick or 302 
human sequences, depending on the type of specimen under analysis. The second step of 303 
the assay allows the simultaneous detection/quantification of four of the most prevalent 304 
genospecies of B. burgdorferi s.l. not only in Portugal but also in Europe. Although both 305 
amplification steps target the same gene, the primers used in the second step were 306 
designed so as to allow the amplification of a distinct, more variable region of flaB, with 307 
sufficient polymorphisms to allow their differential detection with species-specific 308 
TaqMan probes.  309 
In the duplex real-time PCR, DNA from each B. burgdorferi s.l. genospecies, whether 310 
tested individually or simultaneously, a sensitivity of 20 GE was obtained, matching those 311 
achieved with previously reported detection methods (Gooskens et al., 2006; O’Rourke 312 
et al., 2013; Venczel et al., 2016). Furthermore, the assay also revealed high specificity, 313 
as it failed to detect non-Borrelia burgdorferi s.l. flaB sequences. On the other hand, the 314 
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second amplification reaction was carried out in a tetraplex format that allowed the 315 
identification of B. burgdorferi s.s., B. garinii, B. afzelii, and B. lusitaniae with slight 316 
lower sensitivity (200 GE) most probably due to probe competition for their targets.  317 
When testing DNA extracts prepared from field-collected ticks, the first detection step 318 
displayed equivalent high performance when compared with the results obtained with the 319 
pure cultures of B. burgdorferi s.l., with one single exception, the same holds true for the 320 
second step of the assay (tetraplex format). Only one of the samples previously defined 321 
as positive for the presence of Borrelia spp. DNA yielded a negative result, probably due 322 
to the lower detection limit of the assay when dealing with the detection of B. garinii, B. 323 
afzelii, or B. lusitaniae. In all the other situations, the B. burgdorferi s.l. genospecies 324 
identified by the tetraplex assay were 100% concordant with previous identifications 325 
based on DNA sequence analysis.  326 
Since Lyme borreliosis is not considered endemic in Portugal the consequent number of 327 
cases reported annually is small, a situation that is still negatively affected by scarce 328 
knowledge of physicians about LB. In any case, although the number of clinical samples 329 
available for analysis in this study was limited, the assessment of the 330 
sensitivity/specificity of the real-time PCR protocols, was further extended to the analysis 331 
of human serum and CSF samples. While the duplex assay disclosed 100% agreement 332 
with results previously obtained based on nested-PCR protocols followed by DNA 333 
sequencing, only three samples revealed the presence of DNA from Borrelia spp with the 334 
tetraplex assay. The remainder eight nested-PCR-positive samples were found negative 335 
by the tetraplex assay, probably conditioned by a loss of sensitivity when the four probes 336 
are used simultaneously with DNA extracted from these samples, and especially from 337 
CSF samples.  338 
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Previously published studies showed that Borrelia counts in CSF are very low (Nocton 339 
et al., 1996; Schwaiger et al., 2001; Gooskens et al., 2006; Bil-Lula et al., 2015), further 340 
compromising the detection of Borrelia DNA. Since the method here described makes 341 
use of the inclusion of internal controls in each PCR run, the possibility of low-test 342 
sensitivity due to the presence of PCR inhibitors in CSF samples can be excluded. 343 
Moreover, this decrease of sensitivity is characteristic of multiplex assays in general when 344 
clinical samples are tested, and not a feature of the specific tetraplex qPCR assay here 345 
reported. 346 
In any case, and despite the assay's lower performance using CSF, both real-time PCR 347 
protocols were developed to be used at the beginning of the infection, so as to improve 348 
early diagnosis of LB, at a moment where detection of Borrelia should not rely on the use 349 
of CSF samples, being their analysis especially valuable in an advance stages of the 350 
infection (chronic phase).  351 
In conclusion, this two-step multiplex TaqMan real-time PCR assay targeting the flaB 352 
locus, proved to be an efficient method especially when screening for Borrelia infection 353 
in tick samples, and a promising tool for early diagnosis purposes on clinical serum 354 
samples. Moreover, the ability to detect four of the most prevalent B. burgdorferi s.l. 355 
genospecies in Europe in a single-run has both time-saving and cost-reduction added 356 
value when compared with the conventional PCR and sequencing methods. 357 
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Tables and respective legends: 463 
 464 
Table 1 – Sequences of primers and probes designed for this study. 465 
Bbsl – Borrelia burgdorferi sensu lato; Bafz – Borrelia afzelii; Bgar – Borrelia garinii; Blus – Borrelia 466 
lusitaniae; Bbss – Borrelia burgdorferi sensu stricto;1 Probe labeled with FAM (carboxyfluorescein) 467 
fluorophore and BHQ1 quencher; 2Probe labeled with ROX (6-carboxyX-rhodamine) fluorophore and 468 
BHQ2 quencher; 3Probe labeled with Cy5 (Cyanine) fluorophore and BHQ2 quencher; 4Probe labeled with 469 
JOE fluorophore and BHQ1 quencher. 470 
 471 
 472 
 473 
 474 
Primers/Probes Primer/Probe sequence (5’- 3’) Complementary target 
F_Bbsl  TTAATGTTACAACYACAGTTGA 
flaB gene of 
B. burgdorferi s.l. complex 
R_Bbsl   GCTACAATGACAGATGAGGT 
P_Bbsl1 JOE-AAGAGCAAATTTAGGTGCTTTCCAA – BHQ1 
F_Bspp CAAGATGAAGCDATTGCTGTAAA 
flaB gene of 
B. afzelli, B. garinii, 
B. lusitaniae, B. burgdorferi s.s. 
 
R_Bspp CTGCTACAGCACCTTCTCA 
P_Bafz2 ROX – TTCTTGAGCACCCTCTTGAACAGG – BHQ2 
P_Bgar3  Cy5 – CTTGTTGAGCTCCTTCTTGAACAGG – BHQ2 
P_Blus4 JOE – TTGAACACCTTCTTGAGCAGGTGCA – BHQ1 
P_Bbss1 FAM –TCCTTCCTGTTGAACACCCTCTTG – BHQ1 
F_Β-actin  GGCTCYATYCTGGCCTC  
β-actin gene of mammals 
 
F_Β-actin  GCAYTTGCGGTGSACRATG 
P_Β-actin1 FAM – TACTCCTGCTTGCTGATCCACATC – BHQ1  
F_18S rRNA  AGCTAATACATGCAGTGAGC 
18S rRNA gene of ixodids R_18S rRNA  TGATCGCATGGCCACGAG 
P_18S rRNA1 FAM – CGGGTGCTTTTATTAGACCAAGAT – BHQ1 
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Table 2 – Comparison of duplex and tetraplex real-time PCR’s positive samples with 475 
results from previous sequencing for tick samples. 476 
I. ricinus samples (n=50) 
Samples 
(nested-PCR’s 
positive or 
negative) 
Sequencing 
results 
Duplex real – time PCR Tetraplex real-time PCR 
1  B. afzelii 1 positive (Ct ≈ 17) 1 B. afzelii (Ct ≈ 21) 
3 B. burgdorferi s.s. 3 positive 
2 B. burgdorferi s.s. (Ct ≈ 33; Ct ≈ 36) 
1 negative 
8 B. garinii 8 positive (Ct ≈ 17 to Ct ≈ 19) 8 B. garinii (Ct ≈ 16 to Ct ≈ 33) 
12 B. lusitaniae 12 positive (Ct ≈ 18 to Ct ≈ 26) 12 B. lusitaniae (Ct ≈ 20 to Ct ≈ 35) 
26 negative ------- 26 negative 26 negative 
Clinical samples (n= 30) 
Samples 
(nested-PCR’s 
positive or 
negative) 
Sequencing 
results 
Duplex real – time PCR Tetraplex real-time PCR 
5 sera 
6 CSF 
(positive) 
------- 
------- 
11 positive (Ct ≈ 17 to Ct ≈ 36) 
1 serum as B. afzelii (Ct ≈ 29) 
1 serum as B. garinii (Ct ≈ 30) 
1 serum as B. lusitaniae (Ct ≈ 32) 
8 negative (2 sera; 6 CSF) 
15 sera; 4 CSF 
(negative) 
------- 19 negative 19 negative 
 477 
 478 
 479 
 480 
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 481 
Figures legends: 482 
 483 
 484 
 485 
 486 
 487 
 488 
 489 
 490 
 491 
Figure 1 - Representation of the real-time PCR algorithm for identification/quantification 492 
of B. burgdorferi s.l. genospecies. The targeted genes are indicated above the arrows (B. 493 
– Borrelia; Bafz – B. afzelii; Bgar – B. garinii; Blus – B. lusitaniae; Bbss – B. burgdorferi 494 
s.s.). 495 
 496 
 497 
23 
 
 498 
Figure 2 – Illustration of the duplex real-time PCR amplification curve obtained for each 499 
Borrelia burgdorferi s.l. genospecies as a function of the DNA concentration (expressed 500 
as GE) used (A), and respective linear relationship between the logarithm of the starting 501 
concentration of DNA and the amplification Ct values (B). Neg-real-time PCR negative 502 
control, using DNase free water as template, Ct-interception in the minimum threshold 503 
(20 GE), RFU-Relative Fluorescence Units. 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
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 516 
 517 
 518 
 519 
 520 
 521 
 522 
 523 
 524 
Figure 3 - Illustration of the tetraplex real-time PCR amplification curves obtained for 525 
each probe as a function of the DNA concentration used. Similar results were obtained 526 
for all the species/probes tested, and only those obtained for B. lusitaniae are shown (A). 527 
The graph in (B) shows the results obtained when a mixture of the four DNA templates 528 
(B. lusitaniae, B. burgdorferi s.s., B. afzelii and B. garinii) and their specific probes were 529 
used in a tetraplex format. The respective linear relationship between the logarithm of the 530 
starting concentration of DNA and the amplification Ct values is indicated in (C). Neg-531 
real-time PCR negative control using DNase free water as template; Ct-interception in 532 
the minimum threshold (2×102 GE for the four genospecies); RFU-Relative Fluorescence 533 
Units. 534 
 535 
 536 
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 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
Supplementary Figure 1 – Flowchart with the several steps developed for the 546 
optimization and evaluation of the real-time PCR algorithm for B. burgdorferi s.l. 547 
genospecies. 548 
